The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing-Reference-Cited by-同舟云学术

The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing

Published:2020-06-01 Issue:6 Volume:39 Page:1002-1010
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Eisenberg Matthew D.¹,Stone Elizabeth M.²,Pittell Harlan³,McGinty Emma E.⁴

Affiliation:

1. Matthew D. Eisenberg () is an assistant professor in the Department of Health Policy and Management and core faculty member of the Center for Mental Health and Addiction Policy Research, Johns Hopkins Bloomberg School of Public Health, in Baltimore, Maryland.

2. Elizabeth M. Stone is a doctoral student in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health.

3. Harlan Pittell is a doctoral student in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health.

4. Emma E. McGinty is an associate professor in the Department of Health Policy and Management, deputy director of the Center for Mental Health and Addiction Policy Research, and core faculty member of the Center for Gun Policy and Research, Johns Hopkins Bloomberg School of Public Health.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference24 articles.

1. Trends in Opioid Analgesic Abuse and Mortality in the United States

2. A Public Health Strategy for the Opioid Crisis

3. The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy

4. Backstories on the US Opioid Epidemic. Good Intentions Gone Bad, an Industry Gone Rogue, and Watch Dogs Gone to Sleep

5. Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the strategies opioid manufacturers used to recruit health professionals and encourage overprescribing: an analysis of industry documents;BMC Public Health;2024-08-08

2. Invited Commentary: Opioid Prescribing Trends of American Surgeons: Our Roles, Responsibilities, and the Bigger Picture;Journal of the American College of Surgeons;2024-01-16

3. Issues arising from the study design, conduct, and promotion of clinical trials funded by opioid manufacturers: a review of internal pharmaceutical industry documents;Evidence & Policy;2023-11

4. Conflict of interest policies at Australian medical schools;Internal Medicine Journal;2023-06-27

5. Pharmaceutical policies: effects of policies regulating drug marketing;Cochrane Database of Systematic Reviews;2023-06-08